Investigation of the Aural Symptoms and Dizziness in Patients With Temporomandibular Joint Disorders
1 other identifier
observational
120
1 country
2
Brief Summary
120 male and female patients aged between 18-65 years who apply to the outpatient clinic and diagnosed with TMD will be included in the study. Patients will be divided into 3 groups as Muscle Disorders (Group 1), Temporomandibular Joint Disorders (Group 2) and degenerative joint diseas (osteoarthrosis) (Group 3) according to DC/TMD axis I diagnostic criteria. maximum mouth opening, TMJ sound, pain levels, tinnitus, and dizziness are evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2022
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 27, 2022
CompletedFirst Submitted
Initial submission to the registry
May 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedFirst Posted
Study publicly available on registry
June 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedJuly 13, 2022
July 1, 2022
2 months
May 28, 2022
July 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
maximum mouth opening
maximum mouth opening
1 day
right and left lateral movement, deflexion, and deviation
right and left lateral movement, deflexion, and deviation
1 day
TMJ sound
the TMJis palpated with the thumb and middle fingers and the sound heard when opening and closing the mesh was noted.
1 day
visual analog scale
It is use for evaluate the pain intensity.
1 day
Secondary Outcomes (2)
bruxism
1 day
the presence of bruxism, tinnitus and dizzeness
1 day
Interventions
no intervention
Eligibility Criteria
participants aged 18-65 years with TMD
You may qualify if:
- being 18-65 years of age
- diagnosed with TMD
You may not qualify if:
- Lack of cognitive ability to understand test instructions, illliteracy, aphasia, presence of a known psychiatric illness
- Patients under the age of 18 and over the age of 65
- Having another systemic disease that will cause TMD (cancer, rheumatological diseases)
- Presence of disease that will increase a anotherural symptoms or cause d d (presence of disease of vertigo, history of vertigo)
- Presence of a history of cervical pain, cervical spondylosis, cervical disc herniation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Kucukcekmece, 34303, Turkey (Türkiye)
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Kucukcekmece, 34307, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
May 28, 2022
First Posted
June 2, 2022
Study Start
March 27, 2022
Primary Completion
June 1, 2022
Study Completion
June 15, 2022
Last Updated
July 13, 2022
Record last verified: 2022-07